Inhibikase Therapeutics Inc (IKT) USD0.001
How much might it cost?
The following charges are based on an investment of
within a over 5 years assuming Change these assumptions
|Total charges over 5 years|
|Average annual charge|
|Illustrative 5 year value|
|Illustrative 5 year value with no charges applied|
The costs, charges and returns shown are for illustrative purposes only based on the assumptions you have chosen. Please check the costs and charges of your investment and our service before investing. Returns are not guaranteed.
Figures may not add up to the given total due to rounding.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.